Carolyn M. Rucci
General Counsel at Akebia Therapeutics, Inc. (AKBA)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $97K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Feb 4SEC | AKBAAkebia Therapeutics, Inc. | Sell Plan | 16,846641,304 held (−3%) | $1.39 | $23K | -51.8% |
| Feb 4SEC | AKBAAkebia Therapeutics, Inc. | Sell Plan | 25,382615,922 held (−4%) | $1.39 | $35K | -51.8% |
| Feb 4SEC | AKBAAkebia Therapeutics, Inc. | Sell Plan | 27,544588,378 held (−4%) | $1.39 | $38K | -51.8% |
- Sell
General Counsel Carolyn M. Rucci sold $23K of AKBA at $1.39 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Carolyn M. Rucci sold $35K of AKBA at $1.39 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Carolyn M. Rucci sold $38K of AKBA at $1.39 — pre-scheduled 10b5-1 plan sale.